by HTLV | Feb 26, 2026 | Publications
Blood Cancer J. 2026 Feb 25. doi: 10.1038/s41408-026-01453-7. Online ahead of print. ABSTRACT Virus-associated hematological malignancies have become a key focus in oncology research due to their complex pathological mechanisms and unique immune escape capabilities....
by HTLV | Feb 26, 2026 | Publications
Iran J Med Sci. 2026 Feb 1;51(2):154-156. doi: 10.30476/ijms.2025.107439.4188. eCollection 2026 Feb. NO ABSTRACT PMID:41743245 | PMC:PMC12929909 | DOI:10.30476/ijms.2025.107439.4188
by HTLV | Feb 25, 2026 | Publications
Vet Rec Open. 2026 Feb 22;13(1):e70029. doi: 10.1002/vro2.70029. eCollection 2026 Jun. ABSTRACT BACKGROUND: Bovine leukaemia virus (BLV) infection remains a major problem for Japanese Black (Wagyu) cattle, and effective and sustainable control measures are essential...
by HTLV | Feb 25, 2026 | Publications
Cancer Sci. 2026 Feb 25. doi: 10.1111/cas.70349. Online ahead of print. ABSTRACT Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy, and its viral transactivator Tax is central to disrupting host...
by HTLV | Feb 25, 2026 | Publications
Can J Infect Dis Med Microbiol. 2026 Feb 22;2026:8667755. doi: 10.1155/cjid/8667755. eCollection 2026. ABSTRACT Human T-lymphotropic virus Type 1 (HTLV-1) is a globally distributed, oncogenic retrovirus endemic in specific regions, including southwestern Japan,...
by HTLV | Feb 25, 2026 | Publications
Health Sci Rep. 2026 Feb 22;9(2):e71860. doi: 10.1002/hsr2.71860. eCollection 2026 Feb. ABSTRACT BACKGROUND AND AIM: Human T-Lymphotropic Virus Type 1 (HTLV-1), is responsible for serious diseases such as Adult T-cell leukemia/lymphoma (ATLL) and HTLV-1 associated...
